Hirayama, Daisuke
Hyodo, Shinichiro
Morita, Kazuo
Nakase, Hiroshi http://orcid.org/0000-0003-2848-6586
Funding for this research was provided by:
AbbVie G.K.
Article History
Received: 26 July 2023
Accepted: 30 January 2024
First Online: 16 March 2024
Declarations
:
: D.H. has no conflicts of interest to declare. S.H. and K.M. are employees of AbbVie. H.N. has received honorariums and speaker’s fees from AbbVie, Daiichi Sankyo Company, Limited, EA Pharma Co., Ltd., Gilead Sciences, Inc., Janssen Pharmaceutical K.K., JIMRO Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Takeda Pharmaceutical Company Limited, research grants from Hoya Group PENTAX Medical, scholarship grants from Nippon Kayaku Co., Ltd. and Otsuka Pharmaceutical Co., Ltd., and endowed chair from JIMRO Co., Ltd., Kyorin Pharmaceutical Co., Ltd., MIYARISAN Pharmaceutical Co., Ltd., and Mochida Pharmaceutical Co., Ltd.